Synthesis, crystal structure, DNA binding, molecular docking, DFT, Hirshfeld surface analysis, and cytotoxicity of copper (II) complex with malonamide and 2,9-dimethyl-1,10-phenanthroline

A new copper (II) complex, [Cu(dmp)(malon)(H2O)](NO3)2 where malon = malonamide and dmp = 2,9dimethyl-1,10-phenanthroline, has been synthesized and characterized by elemental analysis, FT-IR, UV-Visible and single crystal XRD techniques. The complex was crystallized in a monoclinic system with space group P21/n. Single-crystal XRD studies have established that the copper (II) complex cation has a distorted square-pyramidal geometry, with Jahn-teller distortion occurring in the CuN2O3 core. The DFT/UB3LYP/LANL2DZ level of theory was used to optimize the structure of the present complex. The essential interactions within the crystal structure that lead to molecular packing were identified using Hirshfeld surface analysis. UV-Visible absorption titration, fluorescence, cyclic voltammetry, and viscometric titration studies were used to study the interactions of the present complex with calf thymus DNA (CT-DNA) and propose a partial intercalation binding mechanism. The complex demonstrated strong cytotoxic effects against the human hepatocellular carcinoma cell line (HepG2), and it was discovered to have effective antibacterial and antifungal properties. The efficient binding of the copper (II) complex was observed from molecular docking analysis.

Automated summary

A new copper complex with distorted square-pyramidal geometry was synthesized and characterized. The complex showed partial intercalation binding mechanism with DNA and demonstrated strong cytotoxic effects against a human hepatocellular carcinoma cell line. It also exhibited effective antibacterial and antifungal properties.